Lip cancer in renal transplant patients

Oral Oncology

Volumn 47, Issue 1, 2011, Pages 68-71

  López Pintor, Rosa María ^a   Hernández, Gonzalo ^a   De Arriba, Lorenzo ^a   De Andrés, Amado ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Immunosuppressive therapy; Lip cancer; Oral cancer; Renal transplantation; Risk factors

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; DRUG INDUCED CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIP BIOPSY; LIP CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIP NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SUNLIGHT; YOUNG ADULT;

EID: 79551571083     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.10.017     Document Type: Article

References (32)

1. A. Andrés Cancer incidence after immunosuppressive treatment following kidney transplantation Crit Rev Oncol Hematol 56 2005 71 85
2. A.C. Webster, J.C. Craig, J.M. Simpson, M.P. Jones, and J.R. Chapman Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15, 183 recipients Am J Transplant 7 2007 2140 2151
3. E. González, A. Andrés, and A. Polanco Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation Transplant Proc 41 2009 2332 2333
4. I. Penn The changing pattern of posttransplant malignancies Transplant Proc 23 1991 1101 1103
5. D.W. Thomas, S.V. Seddon, and J.P. Shepherd Systemic immunosuppression and oral malignancy: a report of a case and review of the literature Br J Oral Maxillofac Surg 31 1993 391 393
6. I. Penn Malignancy Surg Clin North Am 74 1994 1247 1257
7. S.B. Gaya, A.J. Rees, R.I. Lechler, G. Williams, and P.D. Mason Malignant disease in patients with long-term renal transplants Transplantation 59 1995 1705 1709
8. I. Penn Post-transplant malignancy: the role of immunosuppression Drug Saf 23 2000 101 113
9. I. Penn Posttransplant malignancies Transplantation Proc 31 1999 1260 1262
10. J. Adami, H. Gäbel, B. Lindelöf, K. Ekström, B. Rydh, and B. Glimelius Cancer risk following organ transplantation; a nationwide cohort study in Sweden Br J Cancer 89 2003 1221 1227
11. C.L. Vajdic, S.P. McDonald, and M.R.E. McCredie Cancer incidence before and after kidney transplantation JAMA 296 2006 2823 2831
12. D.L. Mullen, S.G. Silverberg, I. Penn, and W.S. Hammond Squamous cell carcinoma of the skin and lip in renal homograft recipients Cancer 37 1976 729 734
13. G.N. King, C. Healy, M.T. Glover, J. Kwan, D.M. Williams, and I.M. Leigh Increased prevalence of dysplastic and malignant lip lesions in renal transplant patients New England J Med 332 1995 1052 1057
14. J.G.A.M. de Visscher, J.N. Bouwes, and I. vander Waal Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases Int J Oral Maxillofac Surg 26 1997 120 123
15. E.J. van Zuuren, J.G.A.M. de Visscher, and J.N. Bouwes Bavink Carcinoma of the lip in kidney transplant recipients J Am Acad Dermatol 38 1998 497 499
16. A.A. Mäkitie, M. Lundber, and K. Salmela Head and neck cancer in renal transplant patients in Finland Acta Otolaringol 128 2008 1255 1258
17. M.T. van Leeuwen, A.E. Grulich, S.P. McDonald, M.R. McCredie, J. Amin, and J.H. Stewart Immunosuppression and other risk factors for lip cancer after kidney transplantation Cancer Epidemiol Biomarkers Prev 18 2009 561 569
18. J.M. Campistol Minimizing the risk of posttransplant malignancy Transplant Proc 40 2008 S40 S43
19. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol 45 2009 309 316
20. A.T. Güle, and M. Haberal Lip and oral mucosal lesions in 100 renal transplant patients J Am Acad Dermatol 62 2010 96 101
21. E. Regev, R. Zeltser, and J. Lustmann Lip carcinoma in renal allograft recipient with long-term immunosuppressive therapy Oral Surg Oral Med Oral Pathol 73 1992 412 414
22. O. Hasson Squamous cell carcinoma of the lower lip J Oral Maxillofac Surg 66 2008 259 262
23. IARC. Cancer incidence in five continents, vol. IX. Available from: < http://www-dep.24.fr >.
24. A.E. Grulich, M.T. van Leeuwen, M.O. Falster, and C.M. Vajdic Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 2007 59 67
25. B. Lindelöf, B. Sigurgeirsson, H. Gäbel, and R.S. Stern Incidence of skin cancer in 5356 patients following organ transplantation Br J Dermatol 143 2000 513 519
26. L.C. Spolidorio, D.M.P. Spolidorio, E.M.S. Massucato, K.H. Neppelenbroek, N.H. Campanha, and M.H. Sanches Oral health in renal transplant patients administered cyclosporin A or tacrolimus Oral Dis 12 2006 309 314
27. H.M. Kauffman, W.S. Cherikh, M.A. McBride, Y. Cheng, and D.W. Hanto Post-transplant de novo malignancies in renal transplant patients: the past and present Transplant Int 19 2006 607 620
28. E. Jiménez, E. Marqués, and C. Loinaz Upper aerodigestive tract and lung tumors after liver transplantation Transplant Proc 35 2003 1900 1901
29. L. Rostaing, and N. Kamar MTOR inhibitor/proliferation signal inhibitors: entering or leaving the field? J Nephrol 23 2010 133 142
30. J.M. Campistol, J. Eris, and R. Oberbauer Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation J Am Soc Nephrol 17 2006 581 589
31. R. Salgo, J. Gossmann, and H. Schöfer Switch to a sirolimus-based immunosuppression in long-term renal transplant patients: reduced rate of pre-malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial Am J Transplant 10 2010 1343 1344
32. G. Hernández, L. Arriba, C. Jiménez, J.V. Bagán, B. Rivera, and M. Lucas Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient Oral Oncol 39 2003 87 90